$4.40
2.87% yesterday
Nasdaq, Sep 04, 10:00 pm CET
ISIN
US92859E1082
Symbol
VVOS

Vivos Therapeutics Inc Stock price

$4.40
-0.36 7.56% 1M
+1.16 35.80% 6M
+0.11 2.56% YTD
+1.82 70.54% 1Y
-27.10 86.03% 3Y
-220.35 98.04% 5Y
-220.35 98.04% 10Y
-220.35 98.04% 20Y
Nasdaq, Closing price Thu, Sep 04 2025
-0.13 2.87%

Key metrics

Basic
Market capitalization
$33.0m
Enterprise Value
$36.7m
Net debt
$3.7m
Cash
$4.4m
Shares outstanding
7.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.3 | 2.1
EV/Sales
2.6 | 2.4
EV/FCF
negative
P/B
7.2
Financial Health
Equity Ratio
52.0%
Return on Equity
-140.0%
ROCE
-72.6%
ROIC
-
Debt/Equity
1.8
Financials (TTM | estimate)
Revenue
$14.4m | $15.6m
EBITDA
$-13.5m | $-9.3m
EBIT
$-14.2m | $-11.7m
Net Income
$-14.3m | $-11.5m
Free Cash Flow
$-15.7m
Growth (TTM | estimate)
Revenue
2.6% | 3.8%
EBITDA
-4.3% | 12.4%
EBIT
-5.5% | -4.4%
Net Income
-18.9% | -3.2%
Free Cash Flow
-34.6%
Margin (TTM | estimate)
Gross
55.9%
EBITDA
-93.5% | -59.5%
EBIT
-98.9%
Net
-99.5% | -73.7%
Free Cash Flow
-108.8%
More
EPS
$-1.6
FCF per Share
$-2.1
Short interest
3.9%
Employees
113
Rev per Employee
$130.0k
Show more

Is Vivos Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Vivos Therapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Vivos Therapeutics Inc forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Vivos Therapeutics Inc forecast:

Buy
75%
Hold
25%

Financial data from Vivos Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
14 14
3% 3%
100%
- Direct Costs 6.34 6.34
13% 13%
44%
8.05 8.05
5% 5%
56%
- Selling and Administrative Expenses 22 22
1% 1%
149%
- Research and Development Expense - -
-
-
-13 -13
4% 4%
-94%
- Depreciation and Amortization 0.77 0.77
31% 31%
5%
EBIT (Operating Income) EBIT -14 -14
5% 5%
-99%
Net Profit -14 -14
19% 19%
-100%

In millions USD.

Don't miss a Thing! We will send you all news about Vivos Therapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Vivos Therapeutics Inc Stock News

Neutral
Seeking Alpha
14 days ago
Vivos Therapeutics, Inc. (NASDAQ:VVOS ) Q2 2025 Earnings Conference Call August 19, 2025 5:00 PM ET Company Participants Bradford K. Amman - CFO, Treasurer & Secretary R.
Neutral
GlobeNewsWire
17 days ago
Quarter highlighted by the key acquisition of The Sleep Center of Nevada, which is generating revenue and seeing strong patient demand for Vivos' differentiated array of  highly effective OSA treatments Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a leading medical ...
Neutral
GlobeNewsWire
17 days ago
LITTLETON, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA) in adults and moderate to severe O...
More Vivos Therapeutics Inc News

Company Profile

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Highlands Ranch, CO.

Head office United States
CEO R. Huntsman
Employees 113
Founded 2016
Website vivos.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today